FDA Artificial Intelligence and Machine Learning Fellowship

U.S. Food and Drug Administration (FDA)

FDA-CDRH-

9/30/2027 3:00:00 PM Eastern Time Zone

Applications will be reviewed on a rolling-basis.

Up to 14 research fellowships are available with the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) located in White Oak, Maryland. Oak Ridge Institute for Science and Education (ORISE) Research Participation Programs at the U.S. Food and Drug Administration are educational training programs designed to provide students and recent graduates, opportunities to participate in project-specific research and developmental at the Center for Devices and Radiological Health (CDRH).

The mission of CDRH is to protect and promote public health. CDRH assures that patients and providers have timely and continued access to safe, effective, and high-quality medical devices and safe radiation-emitting products. CDRH provides consumers, patients, caregivers, and providers with understandable and accessible science-based information about products. CDRH facilitates medical device innovation by advancing regulatory science, providing industry with predictable, consistent, transparent, and efficient regulatory pathways, and assuring consumer confidence in devices marketed in the U.S.

The Artificial Intelligence Regulatory Science Program conducts regulatory science research ensuring safe and effective AI/ML-enabled medical devices across rapidly expanding healthcare applications including image processing, disease detection, diagnosis, and therapeutic monitoring. The program addresses critical regulatory challenges posed by AI devices that can continuously learn and adapt, including the unique nature of clinical medical data with low disease prevalence and difficulty obtaining ground truth data.

Major regulatory science gaps include lack of methods for AI algorithm training with limited data, bias analysis and minimization, performance metrics and uncertainty quantification, evaluation of continuously learning algorithms, and post-market monitoring.

• Gain comprehensive understanding of regulatory science approaches for AI/ML-enabled medical devices, including performance assessment methodologies and uncertainty quantification methods.
• Acquire specialized skills in addressing critical data challenges in medical AI, including methods for training algorithms with limited datasets, synthetic data evaluation, and approaches to minimize algorithmic bias.
• Develop expertise in evaluating AI devices that can adapt and learn post-deployment, including understanding evolving algorithms and creating methodologies to assess algorithm performance changes over time.

The mentor(s) for this opportunity are Ravi Samala (ravi.samala.gov) and Aldo Badano (aldo.badano.gov). If you have questions about the nature of the research, please contact the mentor(s).

Spring 2026. Start date is flexible and will depend on a variety of factors.

The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.

The appointment is full time.

The participant will receive a monthly stipend commensurate with educational level and experience.

This opportunity is available to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page of the program website for information about the valid immigration statuses that are acceptable for program participation.…